Mazumdar Claire Insider Trades

Insider Trading History

Track insider trading activity for Mazumdar Claire. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $7.45M 365,130 shares
Last Trade
May 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$301k 15,000 shares
$20.04
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $7.7M 377,152 shares
Last Trade
May 18, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$289k 15,000 shares
$19.29
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $2.98M 146,107 shares
Last Trade
May 18, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$289k 15,000 shares
$19.29
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $7.7M 377,152 shares
Last Trade
Apr 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$352k 15,000 shares
$23.47
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $3.29M 161,107 shares
Last Trade
Apr 20, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$352k 15,000 shares
$23.47
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $7.39M 362,152 shares
Last Trade
Apr 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$354k 15,000 shares
$23.61
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $11.4M 558,432 shares
Last Trade
Apr 16, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$528k 22,760 shares
$23.22
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $7.39M 362,152 shares
Last Trade
Apr 16, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$528k 22,760 shares
$23.22
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $3.59M 176,107 shares
Last Trade
Mar 20, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$29.4k 1,596 shares
$18.41
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $6.96M 340,988 shares
Last Trade
Mar 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$29.4k 1,596 shares
$18.41
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $6.93M 339,392 shares
Last Trade
Mar 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$30.2k 1,596 shares
$18.95
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $7.07M 346,297 shares
Last Trade
Mar 19, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$130k 6,905 shares
$18.79
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $6.93M 339,392 shares
Last Trade
Mar 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$130k 6,905 shares
$18.78
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $3.63M 177,703 shares
Last Trade
Mar 19, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$130k 6,905 shares
$18.79
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $7.06M 345,891 shares
Last Trade
Mar 18, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$120k 6,499 shares
$18.41
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $6.93M 339,392 shares
Last Trade
Mar 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$122k 6,499 shares
$18.84
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $3.77M 184,608 shares
Last Trade
Mar 18, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$120k 6,499 shares
$18.41
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $4.65M 227,873 shares
Last Trade
Mar 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$70.5k 3,817 shares
$18.47
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $6.93M 339,392 shares
Last Trade
Mar 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$71.6k 3,817 shares
$18.75
$20.41
Bicara Therapeutics Common Stock
Bicara Therapeutics Common Stock BCAX
Chief Executive Officer
Holding Value $7M 343,209 shares
Last Trade
Mar 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$70.5k 3,817 shares
$18.47
$20.41

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up